Peripheral arteries are blood vessels that transport blood from the heart to the legs, arms, and different organs apart from the brain and heart. Peripheral artery disease is the standard form of peripheral vascular disease. Peripheral artery revascularization is needed when blood is not provided efficiently to peripheral organs. Peripheral arteries often get obstructed due to plaque formation or narrowing of the peripheral arteries. Peripheral artery revascularization is one of the efficient ways to restore blood flow to peripheral organs. Peripheral artery revascularization is more common in the case of critical limb ischemia and acute limb ischemia.
MARKET DYNAMICS
The peripheral artery revascularisation market is driving due to the increased prevalence of peripheral artery diseases, increasing the global geriatric population. However, the high cost of peripheral artery revascularisation procedures will hamper the market's growth. Moreover, the increase in the prevalence of risk factors such as diabetes, obesity, hypertension, and tobacco use is expected to provide opportunities in the global peripheral artery revascularisation market.
MARKET SCOPE
The "Peripheral Artery Revascularisation Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of peripheral artery revascularisation market with detailed market segmentation by product type, application, and end user. The peripheral artery revascularisation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Peripheral artery revascularisation market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The peripheral artery revascularisation market is segmented on the basis of product type, application, and end user. Based on product type, the market is segmented as stents, grafts, percutaneous trans-luminal angioplasty (PTA) balloons, PTA drug-eluting balloons. Based on application, the market is segmented as lower extremity revascularisation, renal arterial revascularisation, mesenteric arterial revascularisation, abdominal aortic revascularisation. Based on end user, the market is segmented as hospitals, ambulatory surgical centres, specialized clinics, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Peripheral artery revascularisation market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Peripheral artery revascularisation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Peripheral artery revascularisation market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Peripheral artery revascularisation market in these regions.
MARKET PLAYERS
The report covers key developments in the Peripheral artery revascularisation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Peripheral artery revascularisation market are anticipated to have lucrative growth opportunities in the future with the rising demand for Peripheral artery revascularisation in the global market. Below mentioned is the list of few companies engaged in the Peripheral artery revascularisation market.
The report also includes the profiles of key players in Peripheral artery revascularisation market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Boston Scientific Corporation
- AngioDynamics, Inc.
- Cook Medical
- Cardinal Health, Inc.
- C. R. Bard, Inc.
- Medtronic
- Terumo Corporation
- Koninklijke Philips N.V. (The Spectranetics Corporation)
- Integer Holdings Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.